Resolvyx Pharmaceuticals, Inc.

222 Third Street
Suite 1100

Cambridge, MA  02142

Tel: 781.541.5045


Leadership:
Greg Weinhoff, MD
Executive Chairman


Website:
www.resolvyx.com


Information:
info@resolvyx.com

Resolvyx Pharmaceuticals, Inc.

Flagship Partners:  Doug Cole
Initial Investment: 
2005
Status: 
Private

Resolvyx Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development and commercialization of resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Resolvyx's drug R&D programs are focused on characterizing and developing resolvin-based compounds. Resolvyx currently has two programs in clinical development.

Doug Cole is on the Board of Directors.